Melanoma Antigen Family A, 2 (MAGEA2) (N-Term) Peptide
Quick Overview for Melanoma Antigen Family A, 2 (MAGEA2) (N-Term) Peptide (ABIN8105081)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- MAGEA2 Peptide - N-terminal region
-
Sequence
- LGLVGAQAPA TEEQQTASSS STLVEVTLGE VPAADSPSPP HSPQGASSFS
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-MAGEA2 Antibody (ARP59881_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MAGEA2 (Melanoma Antigen Family A, 2 (MAGEA2))
-
Background
-
Background Information: This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80 % sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. This gene has two identical copies at different loci. Alternatively spliced transcript variants encoding the same protein have been identified for this gene.
Alternative Symbols: CT1.2, MAGE2, MAGEA2A, MAGEA2B, MGC131923
-
Molecular Weight
- 35kDa
-
Gene ID
- 4101
-
NCBI Accession
- NP_005352
-
UniProt
- P43356
Target
-
